| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Qualification | |
| Date Qualified: | December 10, 2024 9:30 A.M. |
| Form: | 1-A |
| CIK: | 0001589150 |
| Company Name: | Regen BioPharma Inc |
| File Number: | 024-12505 |
Regen BioPharma (RGBP)
Filed: 11 Dec 24, 12:15am